Glenmark Pharmaceuticals has submitted a copy of Press Release dated July 25, 2016 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Triamcinolone Acetonide Ointment USP, 0.5%’.
The above information is a part of company’s filings submitted to BSE.